Diagnosing Attention Deficit Hyperactivity Disorder in children can take years. Parents will often visit multiple specialists at great expense, sorting through subjective opinions, before arriving at a firm diagnosis. Often after diagnosis, children do not receive the appropriate treatment and to track the efficacy of their treatments is extremely difficult.
DOT, based in Ottawa, Canada, serves the increasing need for more precise and effective wearable consumer devices that diagnose and treat mental disorders like ADHD. We have developed a neurofeedback headset paired with an interactive application to provide a quantitative diagnosis and treatment through gamification of neurofeedback therapy.
“We are thrilled to have won a position in the TMCx cohort here in Houston,” said Yishel Khan, CEO. “This will serve as an entry point for us into the United States. We wish to gain traction in the U.S. market through engaging with associations and champions in the field of children’s health, further refine our product based on costumer feedback and commercialize close to graduation.”